Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	38,983,327
Beginning balance, value at Dec. 31, 2017	$ 38,983	$ 1,579,401	$ (1,539,721)	$ 78,663
Acquisition of Herelab, shares	1,650,000
Acquisition of Herelab, value	$ 1,650	493,350		495,000
Benefical conversion feature discount on note payable		500,000		500,000
Net loss			(933,121)	(933,121)
Ending balance, shares at Sep. 30, 2018	40,633,327
Ending balance, value at Sep. 30, 2018	$ 40,633	2,572,751	(2,472,843)	140,541
Beginning balance, shares at Jun. 30, 2018	40,633,327
Beginning balance, value at Jun. 30, 2018	$ 40,633	2,572,751	(2,229,386)	383,998
Net loss			(243,457)	(243,457)
Ending balance, shares at Sep. 30, 2018	40,633,327
Ending balance, value at Sep. 30, 2018	$ 40,633	2,572,751	(2,472,843)	140,541
Beginning balance, shares at Dec. 31, 2018	40,633,327
Beginning balance, value at Dec. 31, 2018	$ 40,633	2,572,751	(3,153,020)	(539,636)
Stock-based compensation, shares	2,630,220
Stock-based compensation, value	$ 2,631	345,479		348,110
Discount on notes payable		141,300		141,300
Net loss			(1,676,357)	(1,676,357)
Ending balance, shares at Sep. 30, 2019	43,263,547
Ending balance, value at Sep. 30, 2019	$ 43,264	3,059,530	(4,829,377)	(1,726,583)
Beginning balance, shares at Jun. 30, 2019	42,245,929
Beginning balance, value at Jun. 30, 2019	$ 42,246	2,827,568	(4,480,061)	(1,610,247)
Stock-based compensation, shares	1,017,618
Stock-based compensation, value	$ 1,018	128,884		129,902
Discount on notes payable		103,078		103,078
Net loss			(349,316)	(349,316)
Ending balance, shares at Sep. 30, 2019	43,263,547
Ending balance, value at Sep. 30, 2019	$ 43,264	$ 3,059,530	$ (4,829,377)	$ (1,726,583)